Eloxx Pharmaceuticals (ELOX)
13.74
-1.44 (9.49%)
Upcoming Events
Latest Headlines
Form EFFECT Eloxx Pharmaceuticals,
September 21, 2026 6:09 AM - SEC Filing
Leerink Starts Eloxx Pharma (ELOX) at Outperform
September 18, 2026 6:07 AM - StreetInsider
Form S-1 Eloxx Pharmaceuticals,
September 11, 2026 5:29 PM - SEC Filing
Eloxx doses first patients in Phase 2b Alport syndrome trial
September 11, 2026 7:30 AM - StreetInsider
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
September 11, 2026 7:30 AM - PR NewsWire
Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy
August 20, 2026 6:05 AM - StreetInsider
Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Samsara BioCapital, L.P.
August 14, 2026 4:54 PM - SEC Filing
Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Nantahala Capital Management, LLC
August 14, 2026 4:44 PM - SEC Filing
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026 6:00 AM - PR NewsWire
Form 8-K Eloxx Pharmaceuticals, For: Aug 11
August 11, 2026 5:20 PM - SEC Filing
Form 10-Q Eloxx Pharmaceuticals, For: Jun 30
August 11, 2026 5:03 PM - SEC Filing
Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Aberdeen Group plc
July 27, 2026 7:56 AM - SEC Filing
LifeSci Capital Starts Eloxx Pharma (ELOX) at Outperform
July 22, 2026 7:54 AM - StreetInsider
Guggenheim Starts Eloxx Pharma (ELOX) at Buy
July 20, 2026 2:50 AM - StreetInsider
Full Article List
